Zhejiang Pharmaceutical Industry Corp., Ltd., commonly referred to as Zhejiang Pharma, is a prominent player in the pharmaceutical sector, headquartered in China. Established in 1995, the company has made significant strides in the development and manufacturing of a diverse range of pharmaceutical products, including active pharmaceutical ingredients (APIs) and finished dosage forms. With a strong operational presence across various regions in China and beyond, Zhejiang Pharma is renowned for its commitment to quality and innovation. The company’s core offerings include generic medications and specialty pharmaceuticals, distinguished by their adherence to stringent international standards. Zhejiang Pharmaceutical Industry Corp. has achieved notable recognition in the market, positioning itself as a trusted supplier in the global pharmaceutical landscape, thanks to its robust research and development capabilities and a focus on sustainable practices.
How does ZHEJIANG PHARMACEUTICAL INDUSTRY CORP.,LTD.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
ZHEJIANG PHARMACEUTICAL INDUSTRY CORP.,LTD.'s score of 22 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
ZHEJIANG PHARMACEUTICAL INDUSTRY CORP., LTD., headquartered in China, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Zhejiang Hisun Pharmaceutical Co., Ltd., which may influence its climate-related initiatives and reporting practices. Despite the lack of direct emissions data, ZHEJIANG PHARMACEUTICAL INDUSTRY CORP., LTD. is part of a corporate family that may have established climate commitments. However, there are no documented reduction targets or climate pledges available for this entity. The absence of specific initiatives or targets suggests that the company may still be in the early stages of developing its climate strategy. As a subsidiary, it is important to note that any climate commitments or emissions data may be cascaded from its parent company, Zhejiang Hisun Pharmaceutical Co., Ltd. However, no specific information regarding emissions or climate initiatives from this parent company has been provided. In summary, ZHEJIANG PHARMACEUTICAL INDUSTRY CORP., LTD. currently lacks detailed emissions data and defined climate commitments, reflecting a potential area for future development in sustainability practices within the pharmaceutical industry.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
ZHEJIANG PHARMACEUTICAL INDUSTRY CORP.,LTD. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.